×
模态框(Modal)标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框(Modal)标题
×
导航切换
Home
About Journal
Columns
Editorial Board
Guide to Authors
Publishing Ethics
Subscribe
Contacts us
中文
Risk signal mining related to lenvatinib based on the US FDA adverse event reporting system
ZHAO Xiaohong, GUO Mingxing, WANG Xiaojian, LIN Jianrui, CUI Xiangli
Chinese Journal of Pharmacovigilance . 2022, (
11
): 1233 -1237 . DOI: 10.19803/j.1672-8629.20210561